Antidepressants for Depression: Benefits, Risks and Reviews

Evidence checked 2026-09-24 · 7.2636363636364 min read

Updated 24 September 2026. Educational information for adults; not a prescription or instructions for changing medication.

Start with the problem treatment is meant to address

Before discussing a medicine, ask what the clinician is treating. Persistent depression, an anxiety disorder, bipolar depression and pain can involve overlapping symptoms but require different decisions. The fact that a medicine is called an antidepressant does not establish why it was prescribed to a particular person.

Describe the changes that matter most: losing interest in relationships, being unable to concentrate, missing meals or repeatedly waking in distress. Agree on two or three treatment goals beyond feeling better. These provide a practical reference when deciding whether a prescription is helping enough to justify continuing it.

When medication may be considered

Medication is one option within depression care, alongside psychological treatment and practical support. The NICE adult depression guideline advises against routinely offering antidepressants first for less severe depression unless that is the person’s informed preference. More severe illness, previous response and other clinical needs may support a different choice.

Ask what alternatives are available in your circumstances rather than assuming that the only options are medication or doing nothing. A waiting list for therapy does not remove the need for an interim support plan. Equally, choosing medication does not mean that financial stress, grief or relationship difficulties should be ignored.

How the main groups differ

Common groups include selective serotonin reuptake inhibitors, or SSRIs; serotonin and noradrenaline reuptake inhibitors, or SNRIs; and medicines with other actions, such as mirtazapine and bupropion. Older groups include tricyclic antidepressants and monoamine oxidase inhibitors. Availability and licensed indications vary by country.

The NIMH medication overview explains these broad categories. A category describes aspects of how a medicine works, not a reliable ranking of strength. Taking a medicine with more than one neurotransmitter action does not automatically mean that it will work better for you.

Why there is no universally best antidepressant

A prescriber may consider previous benefit, unwanted effects, other prescriptions, physical conditions, age and pregnancy plans. Your priorities also matter. A side effect that one person finds manageable may be unacceptable for someone whose job involves driving, whose appetite is already difficult, or whose sexual functioning is especially affected.

Explain previous treatment accurately. Distinguish a medicine that did not help after an adequate trial from one stopped early because of nausea, cost or difficulties obtaining prescriptions. These are different problems. A useful discussion avoids labeling every incomplete trial as treatment resistance.

What a starting plan should contain

Ask for the medicine’s name, the intended schedule, instructions for missed doses and the contact route for problems. Read the leaflet supplied with your own formulation. Tablets, liquids and modified-release products can have different handling instructions; do not improvise by crushing or dividing them.

Clarify who is responsible for follow-up if a specialist starts treatment but another clinician supplies later prescriptions. Write down the first review date before leaving. A prescription without a review arrangement leaves too much responsibility with someone who may already be exhausted or struggling to organize daily tasks.

Benefits usually develop over time

Antidepressants do not usually produce their full benefit immediately. Some changes in sleep, appetite or concentration may occur before mood improves. The NHS antidepressant guide describes an onset over weeks rather than hours, while recognizing variation between medicines and people.

Ask what timeframe the prescriber considers a fair trial for the proposed treatment. Do not interpret one good day as proof of success or one difficult morning as proof of failure. However, worsening safety, severe reactions or intolerable symptoms should be reported promptly instead of waiting for the trial to finish.

Early follow-up is part of treatment

The NICE guideline recommends an early review, usually within two weeks, with a review after one week for people aged 18 to 25 or when there is a particular concern about suicide risk. The timing may need to be sooner or more frequent according to the person’s circumstances.

A review should ask about actual symptoms and functioning, not simply whether you collected the prescription. Be direct about missed doses, side effects, doubts and access problems. Sharing that information helps the clinician adjust care; it is not an admission that you have failed to cooperate.

Recognizing common unwanted effects

Depending on the medicine, problems may include nausea, bowel changes, headache, disturbed sleep, drowsiness, sexual difficulties or changes in appetite. Some settle, while others persist and need a different approach. The leaflet for your prescription is more useful than assuming every antidepressant has the same effects.

Describe the impact: difficulty driving safely, being unable to eat breakfast or avoiding intimacy because of a new problem. Ask what can be managed, what needs investigation and when a change would be considered. Our side-effects guide helps organize that conversation without recommending unsupervised adjustments.

New agitation or suicidal thoughts need attention

Antidepressant warnings emphasize close monitoring for worsening mood, agitation or suicidal thoughts, particularly in younger people and around treatment changes. Depression itself also carries safety risks. The response should be prompt assessment rather than assuming either that the medicine must be responsible or that the experience is unimportant.

Know whom to contact outside office hours. Tell a trusted person what changes would warrant help when you are comfortable involving them. If you cannot stay safe, seek emergency assistance rather than waiting for a routine medication appointment or relying on an online article.

Screening for a history of mania or hypomania

Mention previous distinct periods of unusually elevated or irritable mood, increased activity and markedly reduced need for sleep. Ordinary relief after a difficult week is not the same as hypomania. The lifetime pattern matters because treatment for bipolar disorder differs from treatment for unipolar depression.

Our bipolar and unipolar depression comparison explains questions that may arise. A sudden increase in energy with little sleep, unusual impulsivity or rapidly changing behavior after treatment starts needs prompt review. Do not decide from an online checklist that you should stop all prescribed treatment.

Check interactions before adding anything

Give the prescriber and pharmacist a complete list of medicines, supplements and recreational substances. Include products used only occasionally, such as pain medicines, cough remedies or sleep aids. A product being sold without a prescription does not make it compatible with every antidepressant.

Combining medicines that affect serotonin can sometimes cause a serious reaction called serotonin syndrome. Urgent symptoms may include marked agitation or confusion with fever, muscle stiffness or twitching. Seek urgent medical help for a concerning reaction and bring the medication list; do not try to diagnose or manage it by changing several medicines yourself.

Measure improvement in a way that matters to you

Use a short record of mood, side effects and a few meaningful activities. For example, note whether you can prepare food, follow a conversation or attend an agreed appointment. This is a practical monitoring suggestion, not a requirement to score every hour of the day.

A symptom questionnaire can supplement this information but should not replace it. Improvement accompanied by an unacceptable adverse effect still deserves discussion. Similarly, someone may have residual symptoms that need attention even though a total score has fallen. Shared decisions depend on the whole balance.

What happens when the first medicine is not enough?

Review the diagnosis, treatment duration, consistency, side effects and factors such as pain, poor sleep or ongoing stress. Ask whether the next step is more time, a different treatment, psychological therapy or specialist input. The answer should follow assessment rather than a rule that everyone must keep escalating medication.

Switching and combining medicines require a prescriber-led plan because interactions and withdrawal can complicate the transition. Keep the written instructions and clarify uncertainties before making the change. See treatment-resistant depression for the questions involved when several adequate approaches have not helped.

Continuation and eventual stopping

Feeling better does not always mean treatment should end immediately. The continuation period depends on recovery, previous episodes, ongoing risks and preferences. Review the reason for continuing at planned intervals, rather than allowing repeat prescriptions to become the only contact with care.

Stopping is usually gradual and individualized. The Royal College of Psychiatrists’ stopping guidance explains why withdrawal needs recognition and support. Some people need a slower reduction than initially expected. A difficult taper does not mean that they have failed or must accept symptoms without help.

Frequently asked questions

Will medication change my personality?

The treatment goal is improved health and functioning, not replacing your identity. Report emotional blunting or feeling unlike yourself so that benefit and unwanted effects can be reviewed together.

Can I choose therapy as well?

Yes, combined care can be appropriate. Ask what each part of treatment is intended to address, how clinicians will communicate and how progress will be reviewed.

Do I have to stay on medication forever?

There is no universal duration. Some people need longer-term treatment; others stop through a planned taper. Decisions should be reviewed with the prescriber rather than assumed at the first appointment.

Urgent help and next steps

Seek emergency help for a severe allergic reaction, seizure, collapse, serious confusion or an inability to stay safe. Contact the prescriber promptly for significant deterioration or adverse effects. For non-emergency planning, bring this article’s questions to your next review and use our stopping guide and crisis information as supporting resources.